医
China Med Service
Best doctors, yours
Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Thyrotoxic cardiomyopathy (I42.800x008) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Stress (takotsubo) cardiomyopathy (I42.800x007) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
Arrhythmogenic left-ventricular cardiomyopathy (I42.800x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is
Right-ventricular cardiomyopathy (I42.800x005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compile
Post-myocarditis cardiomyopathy (I42.800x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
ARVC is fibrofatty RV replacement: ventricular arrhythmia/SCD risk; beta-blocker, ICD, avoid sport, treat HF.
心内科Myocardial cyst (I42.800x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other cardiomyopathy (I42.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Drug-induced cardiomyopathy is myocardial dysfunction from cardiotoxic drugs (anthracyclines); discontinue drug, GDMT, monitor EF.
心内科Cardiomyopathy due to drugs/other external factors (I42.700) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is
Alcoholic cardiomyopathy is dilated cardiomyopathy from chronic alcohol: HF/arrhythmia; abstinence, GDMT for HFrEF.
心内科Constrictive cardiomyopathy (I42.501) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Restrictive cardiomyopathy (I42.500x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other restrictive cardiomyopathy (I42.500) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Congenital cardiomyopathy (I42.401) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Endocardial fibroelastosis (I42.400) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Endomyocardial fibrosis (I42.301) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Loffler endocarditis is eosinophilic endomyocardial fibrosis: restrictive HF; steroids, anticoagulation, endocardiectomy.
心内科Endomyocardial (eosinophilic) disease (I42.300x011) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being co
Endomyocardial (eosinophilic) disease (I42.300) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
|
